APA (7th ed.) Citation

Caillava, A. J., Melli, L. J., Landoni, M., Landivar, S. M., Chinen, I., Couto, A. S., . . . Ciocchini, A. E. (2025). Development of a set of bacterial engineered glycoconjugates as novel serogroup-specific antigens for the serodiagnosis of Escherichia coli O26, O111, O103 and O45 infections associated to hemolytic uremic syndrome. Microbial Cell Factories, 24(1), 1. https://doi.org/10.1186/s12934-025-02694-0

Chicago Style (17th ed.) Citation

Caillava, Ana J., et al. "Development of a Set of Bacterial Engineered Glycoconjugates as Novel Serogroup-specific Antigens for the Serodiagnosis of Escherichia Coli O26, O111, O103 and O45 Infections Associated to Hemolytic Uremic Syndrome." Microbial Cell Factories 24, no. 1 (2025): 1. https://doi.org/10.1186/s12934-025-02694-0.

MLA (9th ed.) Citation

Caillava, Ana J., et al. "Development of a Set of Bacterial Engineered Glycoconjugates as Novel Serogroup-specific Antigens for the Serodiagnosis of Escherichia Coli O26, O111, O103 and O45 Infections Associated to Hemolytic Uremic Syndrome." Microbial Cell Factories, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12934-025-02694-0.